MedPath

Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)

Withdrawn
Conditions
Amyotrophic Lateral Sclerosis
Registration Number
NCT00846560
Lead Sponsor
Rambam Health Care Campus
Brief Summary

The involvement of Lymphocyte type B in Amyotrophic lateral sclerosis (ALS) patients will be compared to lymphocyte in healthy subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • ALS patients who could sign ICF.
Exclusion Criteria
  • No ALS patients age less than 18 years.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rambam Medical center, Neurology Department

🇮🇱

Haifa, Israel

Rambam Medical center, Neurology Department
🇮🇱Haifa, Israel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.